JBIO
Price
$7.19
Change
+$0.30 (+4.35%)
Updated
Jun 6 closing price
Capitalization
231.78M
63 days until earnings call
KPRX
Price
$3.08
Change
-$0.01 (-0.32%)
Updated
Jun 6 closing price
Capitalization
9.38M
Interact to see
Advertisement

JBIO vs KPRX

Header iconJBIO vs KPRX Comparison
Open Charts JBIO vs KPRXBanner chart's image
Jade Biosciences
Price$7.19
Change+$0.30 (+4.35%)
Volume$567.2K
Capitalization231.78M
Kiora Pharmaceuticals
Price$3.08
Change-$0.01 (-0.32%)
Volume$231.86K
Capitalization9.38M
JBIO vs KPRX Comparison Chart
Loading...
JBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JBIO vs. KPRX commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBIO is a Hold and KPRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (JBIO: $7.25 vs. KPRX: $3.00)
Brand notoriety: JBIO and KPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JBIO: 125% vs. KPRX: 87%
Market capitalization -- JBIO: $231.78M vs. KPRX: $9.38M
JBIO [@Biotechnology] is valued at $231.78M. KPRX’s [@Biotechnology] market capitalization is $9.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JBIO’s FA Score shows that 1 FA rating(s) are green whileKPRX’s FA Score has 3 green FA rating(s).

  • JBIO’s FA Score: 1 green, 4 red.
  • KPRX’s FA Score: 3 green, 2 red.
According to our system of comparison, KPRX is a better buy in the long-term than JBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JBIO’s TA Score shows that 3 TA indicator(s) are bullish while KPRX’s TA Score has 4 bullish TA indicator(s).

  • JBIO’s TA Score: 3 bullish, 5 bearish.
  • KPRX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both JBIO and KPRX are a bad buy in the short-term.

Price Growth

JBIO (@Biotechnology) experienced а -3.20% price change this week, while KPRX (@Biotechnology) price change was -3.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

JBIO is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JBIO($232M) has a higher market cap than KPRX($9.38M). JBIO YTD gains are higher at: 173.585 vs. KPRX (-9.091).
JBIOKPRXJBIO / KPRX
Capitalization232M9.38M2,475%
EBITDAN/A2.39M-
Gain YTD173.585-9.091-1,909%
P/E RatioN/A3.67-
RevenueN/A16M-
Total CashN/A29M-
Total DebtN/A72.6K-
FUNDAMENTALS RATINGS
KPRX: Fundamental Ratings
KPRX
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
33
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JBIOKPRX
RSI
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 13 days ago
81%
Bearish Trend 13 days ago
90%
Momentum
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 13 days ago
90%
MACD
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 13 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
83%
Bearish Trend 13 days ago
90%
Advances
ODDS (%)
Bullish Trend 21 days ago
81%
Bullish Trend 25 days ago
79%
Declines
ODDS (%)
Bearish Trend 19 days ago
90%
Bearish Trend 14 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
87%
Bullish Trend 13 days ago
89%
Aroon
ODDS (%)
Bullish Trend 13 days ago
72%
Bullish Trend 13 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
JBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

JBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBIO has been closely correlated with OVID. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBIO jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBIO
1D Price
Change %
JBIO100%
-1.63%
OVID - JBIO
79%
Closely correlated
-0.21%
KPRX - JBIO
32%
Poorly correlated
+1.35%
SYRE - JBIO
29%
Poorly correlated
+0.60%
SLS - JBIO
24%
Poorly correlated
-7.77%
VANI - JBIO
23%
Poorly correlated
N/A
More

KPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPRX has been closely correlated with CDTX. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if KPRX jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
+1.35%
CDTX - KPRX
90%
Closely correlated
-5.46%
NCNA - KPRX
90%
Closely correlated
-3.85%
RNAC - KPRX
89%
Closely correlated
+3.65%
NBY - KPRX
89%
Closely correlated
-0.58%
WINT - KPRX
89%
Closely correlated
+5.12%
More